CDKN2B-AS1 and cancer: Similarly, ANRIL was found to strengthen cancer cell invasion and inhibit cell apoptosis, while the up-regulation of ANRIL could promote the hypoxic osteosarcoma cell invasion and inhibit cell apoptosis [17].